These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20375895)

  • 1. Complications of intravitreal injections.
    Sampat KM; Garg SJ
    Curr Opin Ophthalmol; 2010 May; 21(3):178-83. PubMed ID: 20375895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing the risk of endophthalmitis following intravitreal injections.
    Lad EM; Moshfeghi DM
    Compr Ophthalmol Update; 2006; 7(6):277-84; discussion 285-6. PubMed ID: 17244443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravitreal injections of corticoids].
    Demols P
    Bull Soc Belge Ophtalmol; 2007; (304):117-23. PubMed ID: 17718236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endophthalmitis after intravitreal injections.
    Schwartz SG; Flynn HW; Scott IU
    Expert Opin Pharmacother; 2009 Sep; 10(13):2119-26. PubMed ID: 19586422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intravitreal corticosteroids, evidence-based and otherwise.
    Conti SM; Kertes PJ
    Curr Opin Ophthalmol; 2006 Jun; 17(3):235-44. PubMed ID: 16794435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal steroids for macular edema: the past, the present, and the future.
    Cunningham MA; Edelman JL; Kaushal S
    Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract formation and other complications of intravitreal triamcinolone for macular edema.
    Thompson JT
    Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of intravitreal injections: 2022.
    Patel D; Patel SN; Chaudhary V; Garg SJ
    Curr Opin Ophthalmol; 2022 May; 33(3):137-146. PubMed ID: 35266893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS; Vernon SA; Negi A
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
    Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
    Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
    Gillies MC; Kuzniarz M; Craig J; Ball M; Luo W; Simpson JM
    Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.